Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1957 2
1958 1
1959 1
1960 4
1961 3
1962 12
1963 9
1964 11
1965 16
1966 14
1967 25
1968 26
1969 19
1970 19
1971 14
1972 28
1973 17
1974 12
1975 12
1976 15
1977 18
1978 26
1979 33
1980 25
1981 28
1982 40
1983 57
1984 43
1985 51
1986 65
1987 52
1988 77
1989 65
1990 93
1991 80
1992 85
1993 69
1994 60
1995 87
1996 72
1997 99
1998 93
1999 113
2000 118
2001 101
2002 116
2003 151
2004 142
2005 151
2006 148
2007 157
2008 143
2009 196
2010 171
2011 218
2012 186
2013 206
2014 203
2015 195
2016 196
2017 216
2018 179
2019 163
2020 213
2021 92
Text availability
Article attribute
Article type
Publication date

Search Results

4,991 results
Results by year
Filters applied: . Clear all
Page 1
How COVID-19 induces cytokine storm with high mortality.
Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T. Hojyo S, et al. Among authors: murakami m. Inflamm Regen. 2020 Oct 1;40:37. doi: 10.1186/s41232-020-00146-3. eCollection 2020. Inflamm Regen. 2020. PMID: 33014208 Free PMC article. Review.
Hepcidin and IL-1Ī².
Kanamori Y, Murakami M, Sugiyama M, Hashimoto O, Matsui T, Funaba M. Kanamori Y, et al. Among authors: murakami m. Vitam Horm. 2019;110:143-156. doi: 10.1016/bs.vh.2019.01.007. Epub 2019 Feb 2. Vitam Horm. 2019. PMID: 30798809 Review.
Signalling input from divergent pathways subverts BĀ cell transformation.
Chan LN, Murakami MA, Robinson ME, Caeser R, Sadras T, Lee J, Cosgun KN, Kume K, Khairnar V, Xiao G, Ahmed MA, Aghania E, Deb G, Hurtz C, Shojaee S, Hong C, Pƶlƶnen P, Nix MA, Chen Z, Chen CW, Chen J, Vogt A, HeinƤniemi M, Lohi O, Wiita AP, Izraeli S, Geng H, Weinstock DM, MĆ¼schen M. Chan LN, et al. Among authors: murakami ma. Nature. 2020 Jul;583(7818):845-851. doi: 10.1038/s41586-020-2513-4. Epub 2020 Jul 22. Nature. 2020. PMID: 32699415 Free PMC article.
FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.
Weiss A, Adler F, Buhles A, Stamm C, Fairhurst RA, Kiffe M, Sterker D, Centeleghe M, Wartmann M, Kinyamu-Akunda J, Schadt HS, Couttet P, Wolf A, Wang Y, Barzaghi-Rinaudo P, Murakami M, Kauffmann A, Knoepfel T, Buschmann N, Leblanc C, Mah R, Furet P, Blank J, Hofmann F, Sellers WR, Graus Porta D. Weiss A, et al. Among authors: murakami m. Mol Cancer Ther. 2019 Dec;18(12):2194-2206. doi: 10.1158/1535-7163.MCT-18-1291. Epub 2019 Aug 13. Mol Cancer Ther. 2019. PMID: 31409633 Free article.
4,991 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page